Can a single decision alter the profitability of your dairy for years to come? In this episode, The Bullvine Podcast challenges the status quo in calf health by unpacking the real-world economics and science behind the CDCB's new genomic evaluations for calf disease resistance—rolling out April 2026. What if your biggest barrier to profitability isn't genomics or technology, but flawed management? Discover how a data-driven approach to selection could spell either a breakthrough or a costly distraction, depending on your operation’s readiness. Key Takeaways: Understand whether CDCB's genomic calf health evaluations will actually deliver ROI for your herd—or if management needs to come first. Discover why, for some producers, these groundbreaking evaluations could be free, while others might face up to $40,000 in costs—and how to leverage your investment. Weigh hard-hitting evidence about the impact of scours and respiratory disease on the bottom line and why 6% pre-weaning mortality can cost a 1,000-cow dairy $350,000 a year. Learn entry strategies—from heifer-only testing to phased implementation—that minimize cost and risk. Hear bold analysis on how limited data participation, heritability rates, and major players like Zoetis could shape industry winners and losers. Examine sharp, actionable questions to ask your DRPC before you invest—and metrics every producer should track to avoid regret. Deeper Dive - Why Listen: This episode reframes the calf health conversation with pioneering data and sober analysis on CDCB’s new genomic evaluations for scours and respiratory disease resistance. Packed with cost breakdowns, case-based scenarios, and battle-tested management advice, it’s essential listening for any forward-thinking dairy producer or herd manager. You'll get not just numbers but context: Why do only 12% of farms’ records shape these new predictions, and what does that mean for your herd's genetics? How can international precedents and smart heifer-testing strategies lower your costs to zero—or at least avoid overspending on unproven tech? Are CDCB’s or Zoetis’ rankings likely to make a difference in day-to-day profitability? If your operation’s success depends on both innovation and business pragmatism, you’ll find answers, cautions, and real-world decision tools here. Resources & Engagement: Stay ahead of the curve and subscribe for more high-impact, no-nonsense dairy industry insights from The Bullvine Podcast. Explore our website, https://www.thebullvine.com/genetic-evaluation-system/the-3500-calf-question-what-dairy-farmers-need-to-know-about-april-2026s-new-cdcb-calf-health-evaluations/ for full articles, referenced studies, cost calculators, and practical resources mentioned in this episode. Have a strategy for managing calf health or a question about genomics? Join the discussion on our social channels—your insights drive the conversation forward. Don’t just follow the herd—be the leader who moves it forward.
